Literature DB >> 21451000

Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer.

Annemarie Boleij1, Carla M J Muytjens, Sarah I Bukhari, Nadège Cayet, Philippe Glaser, Peter W M Hermans, Dorine W Swinkels, Albert Bolhuis, Harold Tjalsma.   

Abstract

BACKGROUND: The prevalence of Streptococcus gallolyticus subsp gallolyticus ( Streptococcus bovis biotype I) endocarditis is in general low but very often linked to colorectal cancer. Therefore, this study aimed to reveal the virulence characteristics that distinguish this opportunistic pathogen from a panel of (closely related) intestinal bacteria.
METHODS: The route of infection was reconstructed in vitro with adhesion, invasion, and translocation assays on differentiated Caco-2 cells. Furthermore, cellular immune responses upon infection and bacterial biofilm formation were analyzed in a comparative manner.
RESULTS: S. gallolyticus subsp gallolyticus strains were demonstrated to have a relative low adhesiveness and could not internalize epithelial cells. However, these bacteria were uniquely able to paracellularly cross a differentiated epithelium without inducing epithelial interleukin 8 or 1β responses. Importantly, they had an outstanding ability to form biofilms on collagen-rich surfaces, which in vivo are found at damaged heart valves and (pre)cancerous sites with a displaced epithelium.
CONCLUSIONS: Together, these data show that S. gallolyticus subsp gallolyticus has a unique repertoire of virulence factors that facilitate infection through (pre)malignant colonic lesions and subsequently can provide this bacterium with a competitive advantage in (1) evading the innate immune system and (2) forming resistant vegetations at collagen-rich sites in susceptible patients with colorectal cancer.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21451000     DOI: 10.1093/infdis/jiq169

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  55 in total

1.  Surface-affinity profiling to identify host-pathogen interactions.

Authors:  Annemarie Boleij; Coby M Laarakkers; Jolein Gloerich; Dorine W Swinkels; Harold Tjalsma
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 2.  A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects.

Authors:  Harold Tjalsma; Annemarie Boleij; Julian R Marchesi; Bas E Dutilh
Journal:  Nat Rev Microbiol       Date:  2012-06-25       Impact factor: 60.633

3.  Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients.

Authors:  Annemarie Boleij; Rian Roelofs; Camille Danne; Samuel Bellais; Shaynoor Dramsi; Ikuko Kato; Harold Tjalsma
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-19

Review 4.  Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.

Authors:  C T Peterson; V Sharma; L Elmén; S N Peterson
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

5.  Killing bacteria within biofilms by sustained release of tetracycline from triple-layered electrospun micro/nanofibre matrices of polycaprolactone and poly(ethylene-co-vinyl acetate).

Authors:  Nour Alhusein; Paul A De Bank; Ian S Blagbrough; Albert Bolhuis
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

6.  Contribution of Streptococcus mutans Strains with Collagen-Binding Proteins in the Presence of Serum to the Pathogenesis of Infective Endocarditis.

Authors:  Masatoshi Otsugu; Ryota Nomura; Saaya Matayoshi; Noboru Teramoto; Kazuhiko Nakano
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

Review 7.  The gut microbiome and colorectal cancer: a review of bacterial pathogenesis.

Authors:  Jessica D Dahmus; Drew L Kotler; David M Kastenberg; C Andrew Kistler
Journal:  J Gastrointest Oncol       Date:  2018-08

8.  Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium.

Authors:  Julia Butt; William J Blot; Lauren R Teras; Kala Visvanathan; Loïc Le Marchand; Christopher A Haiman; Yu Chen; Ying Bao; Howard D Sesso; Sylvia Wassertheil-Smoller; Gloria Y Ho; Lesley F Tinker; Richard M Peek; John D Potter; Timothy L Cover; Laura H Hendrix; Li-Ching Huang; Tim Waterboer; Michael Pawlita; Meira Epplein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-23       Impact factor: 4.254

Review 9.  Bacterial oncogenesis in the colon.

Authors:  Christine Dejea; Elizabeth Wick; Cynthia L Sears
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

10.  The Pil3 pilus of Streptococcus gallolyticus binds to intestinal mucins and to fibrinogen.

Authors:  Mariana Martins; Constance Porrini; Laurence du Merle; Camille Danne; Catherine Robbe-Masselot; Patrick Trieu-Cuot; Shaynoor Dramsi
Journal:  Gut Microbes       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.